1st Quarter - Report

JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC

Firm
Client
Income
—
Expenses
$1,480,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

11 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

-Issues related to the NAFTA/USMCA renegotiation issues. -Issues related to new tariff proclamations and retaliation.

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
DAVID KAVANAUGH —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Taxation/Internal Revenue Code TAX

- Issues related to spending and linked to corporate tax rate - H.R.1711/S.780 - No Tax Breaks for Outsourcing Act, regarding all provisions - H.R.1712/S.779 - Stop Tax Haven Abuse Act, regarding all provisions - Issues related to replacing G1LT1 global average method with a per country minimum. - Issues related to CFC look through. - Issues related to the implementation of the Tax Cut and Jobs Act of 2017 - H.R. 1922/S. 1089 -"Restoring Access to Medication Act of 2019", regarding all provisions. - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding tax provisions and future stimulus bills.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
DARREL C JODREY —
DAVID KAVANAUGH —
RILEY SWINEHART —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1711 (116th), S. 779 (116th), S. 780 (116th), H.R. 1922 (116th), H.R. 1712 (116th), S. 1089 (116th), H.R. 748 (116th), S. 3458 (116th)

Science/Technology SCI

- Issues related to data privacy. - Issues related to artificial intelligence.

LobbyistCovered position, as disclosed
LEIF BRIERLEY —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Copyright/Patent/Trademark CPT

- Patent Trade Office reforms - H.R.1520, "Purple Book Continuity Act of 2019", regarding all provisions - H.R.1503, "Orange Book Transparency Act of 2019", regarding all provisions - H.R.1499 "Protecting Consumer Access to Generic Drugs Act of 2019", regarding all provisions - S.659, "Biologic Patent Transparency Act", regarding all provisions. - S. 1419, "Early Participation in Regulations Act of 2019", regarding all provisions

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
ANNE BRUCE —
DAVID KAVANAUGH —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1503 (116th), S. 1419 (116th), H.R. 1520 (116th), H.R. 1499 (116th), S. 659 (116th)

Veterans VET

- Issues related to VA medical device procurement issues

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
ANNE BRUCE —
RILEY SWINEHART —

Contacted: White House Office; SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

- Issues related to reimbursement

LobbyistCovered position, as disclosed
MICHAEL BARNARD —
ANNE BRUCE —
RILEY SWINEHART —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

-Issues related to FY2020 Appropriations, specifically the Special Olympics, The Global Fund, Food & Drug Administration, Commerce, Interior, National Institutes of Health and Environmental Protection Agency budgets. -Issues related to frontline health workers

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LEIF BRIERLEY —
DARREL C JODREY —
MEGHAN DRENAN STONE —
KELLY WATERS —

Contacted: White House Office; HOUSE OF REPRESENTATIVES; SENATE

Labor Issues/Antitrust/Workplace LBR

- Issues related to corporate governance - Issues related to diversity & Inclusion

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
LARRY CAMM New —
KELLY WATERS —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Health Issues HCR

- H.R. 863 - DXM Abuse Prevention Act of 2019, regarding all provisions - S. 726 - Personal Care Products Safety Act, regarding all provisions - Issues related to the regulation of over-the-counter drugs - Issues related to cosmetic regulatory reform - Issues related to cosmetic animal testing - Issues related to biosimilars - Issues related to maternal mortality - Issues related to contact lens safety - Issues related to medical product communications - Issues related to medical product review - Issues related to ingredient safety - Issues related to diversity in clinical trials - Issues related to health care pricing transparency - Issues related to peripheral artery disease - H.R. 3, "Elijah E. Cummings Lower Drug Costs Now Act", regarding all provisions - Issues related to drug importation - S. 2543, "Prescription Drug Pricing Reduction Act of 2019", regarding all provisions - H.R. 19, "Lower Costs, More Cures Act of 2019", regarding all provisions - H.R. 748/ S. 3458, "'Coronavirus Aid, Relief, and. Economic Security Act'', regarding all provisions - H.R. 6074, "Coronavirus Preparedness and Response Supplemental Appropriations Act", regarding all provisions - H.R. 6201, "Families First Coronavirus Response Act", regarding all provisions - H.R. 3975, the Contact Lens Prescription Verification Modernization Act, regarding all provisions - H.R. 5663, the Safeguarding Therapeutics Act, regarding all provisions - Issues related to counterfeit health care goods - S. 3468, Preventing Essential Medical Device Shortages Act of 2020 - Issues related to counterfeit medical devices and combination products and authority to destroy counterfeit medical products - Issues related to reporting medical device shortages - Issues related to pandemic response - S. 2740, "Over the Counter Monograph Safety, Innovation, and Reform Act of 2019", regarding all provisions - H.R. 5279, "Cosmetic Safety Enhancement Act", regarding all provisions - H.R. 4296, "Safe Cosmetics and Personal Care Products Act of 2019", regarding all provisions

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
MICHAEL BARNARD —
LEIF BRIERLEY —
ANNE BRUCE —
LARRY CAMM —
DARREL C JODREY —
DAVID KAVANAUGH —
ABIGAIL PINKELE New Legislative Director, Rep. Gene Greene - 3/03 - 3/12
MEGHAN DRENAN STONE —
RILEY SWINEHART —
KELLY WATERS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 726 (116th), H.R. 5279 (116th), H.R. 3975 (116th), H.R. 863 (116th), H.R. 3 (116th), H.R. 748 (116th), H.R. 19 (116th), H.R. 5663 (116th), S. 2740 (116th), S. 3458 (116th), H.R. 4296 (116th), S. 2543 (116th), S. 3468 (116th), H.R. 6201 (116th), H.R. 6074 (116th)

Environment/Superfund ENV

- H.R. 1834 - Defending our National Marine Sanctuaries from Damaging Chemicals Act of 2019, regarding all provisions - H.R. 2588/S. 1371 - Oxybenzone and Octinoxate Impact Study Act of 2019, regarding all provisions - H.R. 2587/S. 1375 - Reef Safe Act of 2019, regarding all provisions - Issues related to sterilization of medical devices - Issues regarding environmental sustainability

LobbyistCovered position, as disclosed
DARREL C JODREY —
MEGHAN DRENAN STONE —
RILEY SWINEHART —
KELLY WATERS —

Contacted: SENATE; White House Office; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2588 (116th), H.R. 1834 (116th), H.R. 2587 (116th), S. 1375 (116th), S. 1371 (116th)

Torts TOR

- Issues related to civil justice reform.

LobbyistCovered position, as disclosed
JANE MARGARET ADAMS —
RILEY SWINEHART —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.